The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

The set of paired plasma and CSF samples utilized in the verification stage contained samples collected at three hospitals within Sweden. All patients were examined and diagnosed by a neurologist and ...

Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively ...

Radboudumc researchers Kirsten van Abeelen, Edwin Ardiansyah, Sofiati Dian, Vinod Kumar, Reinout van Crevel and Arjan van Laarhoven used metabolomics to study cerebrospinal fluid (CSF) samples from ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...

Radboudumc researchers used metabolomics to study cerebrospinal fluid (CSF) samples from tuberculous meningitis patients in ...

A study provides evidence of blood-brain barrier injury and significant neuroinflammation in women diagnosed with eclampsia.

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

The FDA cleared the test for early detection of amyloid plaques associated with Alzheimer’s in people aged 55 years and older ...

The brain has chambers called ventricles (cavities) that normally contain fluid. This fluid is called cerebrospinal fluid (CSF). It cushions the brain and spinal cord. Normally, your body makes just ...

10 this parameter has been obtained retrospectively in a proportion of the patients in whom a CSF sample obtained in the appropriate container existed after the test became clinically available in the ...